While the changing strains of the influenza virus and disruptions in global production have delayed the supply of vaccines for this disease this year, it has also created an opportunity for the formation of informal markets and the sale of vaccines at multi-million-toman prices in cyberspace; a market that the Ministry of Health and the Food and Drug Administration have warned against purchasing from, emphasizing that vaccines moved outside the official network are not reliable in terms of quality and effectiveness.
The Booming Influenza Vaccine Market; Warning About Multi-Million-Toman Vaccines in Cyberspace
This year, delays in influenza vaccine supply due to virus strain changes and global production issues have led to the emergence of informal markets selling vaccines at exorbitant prices. The Iranian Ministry of Health and the Food and Drug Administration have issued warnings against these unofficial sources, stressing concerns over quality and effectiveness.
👥 Key Players
📰 What Happened
Due to delays in the supply of influenza vaccines, informal markets have emerged in Iran selling vaccines at high prices. The Ministry of Health and the Food and Drug Administration have issued warnings against these unofficial sources, citing concerns over quality.
- Influenza vaccine supply has been disrupted by changing virus strains and global production issues.
- Vaccines sold in informal markets are priced in multi-million tomans and are deemed unreliable.
💡 Why It Matters
📚 Background
Influenza vaccines are crucial for preventing seasonal outbreaks, and disruptions can lead to increased illness and strain on healthcare systems.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%